GoBroad's Clinical Research Network & Experts
August 17, 2026
GoBroad is not only a treatment provider but a research platform: hundreds of ongoing clinical trials, dozens of presentations at international hematology conferences, and publications in leading medical journals.
A Platform Integrating Treatment and Research
GoBroad Healthcare Group was established in 2017 with a model that integrates medical care and research. The network now includes 8 hospitals in Beijing, Shanghai and Guangzhou, with nearly 1,500 beds in total, focused on hematology and oncology.
What sets it apart is that GoBroad treats clinical research as a core part of care, not separate from it. As a result, patients gain early access to new therapies.
Scale of Clinical Research
- Hundreds of clinical trials underway across different phases.
- Participation in international research collaboration networks connecting many sites.
- Focus on unmet targets in hematology and rare diseases.
A Presence on the International Scientific Stage
GoBroad regularly presents results at leading hematology and oncology conferences:
- Multiple presentations at ASH (American Society of Hematology).
- Presentations at EHA (European Hematology Association) and ASCO (American Society of Clinical Oncology).
- Research published in respected journals such as The Lancet, Journal of Clinical Oncology, Journal of Hematology & Oncology.
A Team of Leading Experts
GoBroad brings together experienced specialists in hematology, hematopoietic stem cell transplantation and cell therapy. The combination of clinical experts and research capacity creates a patient advantage: treatment on the most current protocols with the chance to join advanced studies.
Related Images
